Sarissa Capital Management
Latest statistics and disclosures from Sarissa Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are INVA, IRWD, AMRN, NBIX, CYTK, and represent 82.87% of Sarissa Capital Management's stock portfolio.
- Added to shares of these 2 stocks: BHVN, BIIB.
- Started 1 new stock position in BIIB.
- Reduced shares in these 1 stock: INVA (-$5.5M).
- Sarissa Capital Management was a net seller of stock by $-5.0M.
- Sarissa Capital Management has $178M in assets under management (AUM), dropping by 12.84%.
- Central Index Key (CIK): 0001577524
Tip: Access up to 7 years of quarterly data
Positions held by Sarissa Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 10 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Innoviva (INVA) | 24.1 | $43M | -11% | 1.9M | 22.71 |
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 21.7 | $39M | 9.2M | 4.21 |
|
|
| Amarin Corp Sponsored Adr (AMRN) | 15.0 | $27M | 1.7M | 15.94 |
|
|
| Neurocrine Biosciences (NBIX) | 11.0 | $20M | 117k | 168.53 |
|
|
| Cytokinetics Com New (CYTK) | 10.9 | $20M | 229k | 85.19 |
|
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 10.4 | $19M | 167k | 110.94 |
|
|
| Biohaven (BHVN) | 4.9 | $8.7M | +3% | 582k | 14.88 |
|
| Regeneron Pharmaceuticals (REGN) | 1.5 | $2.6M | 4.2k | 623.54 |
|
|
| Vor Biopharma Com New (VOR) | 0.3 | $468k | 25k | 18.41 |
|
|
| Biogen Idec (BIIB) | 0.1 | $205k | NEW | 950.00 | 216.06 |
|
Past Filings by Sarissa Capital Management
SEC 13F filings are viewable for Sarissa Capital Management going back to 2013
- Sarissa Capital Management 2026 Q2 filed Aug. 14, 2026
- Sarissa Capital Management 2026 Q1 filed May 15, 2026
- Sarissa Capital Management 2025 Q4 filed Feb. 17, 2026
- Sarissa Capital Management 2025 Q3 filed Nov. 14, 2025
- Sarissa Capital Management 2025 Q2 filed Aug. 14, 2025
- Sarissa Capital Management 2025 Q1 filed May 15, 2025
- Sarissa Capital Management 2024 Q4 filed Feb. 14, 2025
- Sarissa Capital Management 2024 Q3 filed Nov. 14, 2024
- Sarissa Capital Management 2024 Q2 filed Aug. 14, 2024
- Sarissa Capital Management 2024 Q1 filed May 15, 2024
- Sarissa Capital Management 2023 Q4 filed Feb. 14, 2024
- Sarissa Capital Management 2023 Q3 filed Nov. 14, 2023
- Sarissa Capital Management 2023 Q2 filed Aug. 14, 2023
- Sarissa Capital Management 2023 Q1 filed May 15, 2023
- Sarissa Capital Management 2022 Q4 filed Feb. 14, 2023
- Sarissa Capital Management 2022 Q3 filed Nov. 14, 2022